Renaissance Technologies’s iTeos Therapeutics ITOS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6M Sell
602,100
-43,500
-7% -$434K 0.01% 1404
2025
Q1
$3.85M Sell
645,600
-191,600
-23% -$1.14M 0.01% 1581
2024
Q4
$6.43M Buy
837,200
+300,800
+56% +$2.31M 0.01% 1283
2024
Q3
$5.48M Sell
536,400
-23,200
-4% -$237K 0.01% 1387
2024
Q2
$8.3M Sell
559,600
-157,700
-22% -$2.34M 0.01% 1030
2024
Q1
$9.78M Buy
717,300
+18,400
+3% +$251K 0.02% 997
2023
Q4
$7.65M Buy
698,900
+304,900
+77% +$3.34M 0.01% 1072
2023
Q3
$4.31M Sell
394,000
-19,200
-5% -$210K 0.01% 1398
2023
Q2
$5.47M Buy
413,200
+83,300
+25% +$1.1M 0.01% 1384
2023
Q1
$4.49M Buy
329,900
+12,800
+4% +$174K 0.01% 1536
2022
Q4
$6.19M Sell
317,100
-75,800
-19% -$1.48M 0.01% 1381
2022
Q3
$7.49M Buy
392,900
+60,600
+18% +$1.15M 0.01% 1190
2022
Q2
$6.85M Buy
332,300
+198,100
+148% +$4.08M 0.01% 1332
2022
Q1
$4.32M Buy
134,200
+101,100
+305% +$3.25M 0.01% 1704
2021
Q4
$1.54M Buy
+33,100
New +$1.54M ﹤0.01% 2354